(Q47918627)

6 February 2018

title

PlA2 polymorphism and efficacy of aspirin. (English)

1 reference

6 February 2018

1 reference

G E Cooke

1

1 reference

6 February 2018

P F Bray

2

1 reference

6 February 2018

J D Hamlington

3

1 reference

6 February 2018

D M Pham

4

1 reference

6 February 2018

P J Goldschmidt-Clermont

5

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 April 1998

1 reference

6 February 2018

published in

The Lancet

1 reference

6 February 2018

volume

351

1 reference

6 February 2018

issue

9111

1 reference

6 February 2018

page(s)

1253

1 reference

6 February 2018

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2979320-X

7 January 2021

A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2979320-X

7 January 2021

Association of the platelet Pl(A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2979320-X

7 January 2021

PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2979320-X

7 January 2021

10.1016/S0140-6736(05)79320-X

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

9643753

1 reference

6 February 2018